Comparison of Two Regimens of Anesthesia for Children Undergoing Magnetic Resonance Imaging (MRI) in General Anesthesia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Niels Anker Pedersen, Glostrup University Hospital,Copenhagen
ClinicalTrials.gov Identifier:
NCT00949507
First received: July 29, 2009
Last updated: May 24, 2013
Last verified: May 2013

July 29, 2009
May 24, 2013
October 2008
May 2011   (final data collection date for primary outcome measure)
postanaesthetic recovery and behavioral score [ Time Frame: 0-24 hours hours postoperatively ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00949507 on ClinicalTrials.gov Archive Site
Time span of the recovery process [ Time Frame: 0-3 hours postoperatively ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Comparison of Two Regimens of Anesthesia for Children Undergoing Magnetic Resonance Imaging (MRI) in General Anesthesia
Comparison of Two Regimens of Anesthesia for Children Undergoing MRI in General Anesthesia. Advantages, Disadvantages and Time Consumption Regarding the Two Regimens.

Comparison of two regimens (Sevorane/LMA ctr. Propofol/Remifentanil) for children undergoing MRI in general anesthesia.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

120 children ASA 1-2 aged 1 to 10 yrs. scheduled for MRI in general anesthesia

  • General Anesthesia
  • Children
  • MRI
  • Sevoflurane
  • Propofol/Remifentanil
Not Provided
  • anaesthesia using propofol
    the children are anaesthetized using intravenous anaesthesia with propofol and remifentanil; a binasal catheter is used for administration of oxygen during the anaesthesia
  • anaesthesia using sevoflurane
    the patients are anaesthetized using sevoflurane 1 MAC; a laryngeal mask is used
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
120
May 2011
May 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • children aged 1 to 10 yrs.
  • ASA 1-2

Exclusion Criteria:

  • Allergy to soya (propofol)
  • Allergy to Pentobarbital
  • Allergy to Remifentanil
  • Allergy to Sevoflurane
  • Children undergoing blood tests or further examinations in conjunction with the MRI
  • Children with unexplained fever
  • Children which are evaluated not to be able to keep a open airway
Both
1 Year to 10 Years
No
Contact information is only displayed when the study is recruiting subjects
Denmark
 
NCT00949507
2008-209, EudraCT 2008-002690-12, 2008-41-2609, 2612-3762, H-A-2008-060
Yes
Niels Anker Pedersen, Glostrup University Hospital,Copenhagen
Niels Anker Pedersen
Not Provided
Not Provided
Glostrup University Hospital, Copenhagen
May 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP